FDA Inspection 1089916 — Amneal Pharmaceuticals of New York, LLC
The FDA completed an inspection of Amneal Pharmaceuticals of New York, LLC on April 18, 2019 in Brookhaven, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brookhaven, NY (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)